Porphyrin measurement, total, plasma
Related entities
Findings (27)
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups
None
nullAnti-miR-33 treatment produced no difference in total plasma cholesterol or LDL cholesterol between treatment and control groups over 12 weeks, demonstrating that the HDL-raising effect is selective a
Effect: null; no difference between groups